A dominant-negative thyroid hormone receptor blocks amphibian metamorphosis by retaining corepressors at target genes

被引:105
作者
Buchholz, DR [1 ]
Hsia, SCV [1 ]
Fu, LZ [1 ]
Shi, YB [1 ]
机构
[1] NICHD, LGRD, Unit Mol Morphogenesis, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/MCB.23.19.6750-6758.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The total dependence of amphibian metamorphosis on thyroid hormone (T-3) provides a unique vertebrate model for studying the molecular mechanism of T-3 receptor (TR) function in vivo. In vitro transcription and developmental expression studies have led to a dual function model for TR in amphibian development, i.e., TRs act as transcriptional repressors in premetamorphic tadpoles and as activators during metamorphosis. We examined molecular mechanisms of TR action in T-3-induced metamorphosis by using dominant-negative receptors (dnTR) ubiquitously expressed in transgenic Xenopus laevis. We showed that T-3-induced activation of T-3 target genes and morphological changes are blocked in dnTR transgenic animals. By using chromatin immunoprecipitation, we show that dnTR bound to target promoters, which led to retention of corepressors and continued histone deacetylation in the presence of T-3. These results thus provide direct in vivo evidence for the first time for a molecular mechanism of altering gene expression by a dnTR. The correlation between dnTR-mediated gene repression and inhibition of metamorphosis also supports a key aspect of the dual function model for TR in development: during T-3-induced metamorphosis, TR functions as an activator via release of corepressors and promotion of histone acetylation and gene activation.
引用
收藏
页码:6750 / 6758
页数:9
相关论文
共 77 条
[1]   GENETIC-ANALYSIS OF 29 KINDREDS WITH GENERALIZED AND PITUITARY RESISTANCE TO THYROID-HORMONE - IDENTIFICATION OF 13 NOVEL MUTATIONS IN THE THYROID-HORMONE RECEPTOR-BETA GENE [J].
ADAMS, M ;
MATTHEWS, C ;
COLLINGWOOD, TN ;
TONE, Y ;
BECKPECCOZ, P ;
CHATTERJEE, KK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :506-515
[2]  
[Anonymous], 1989, STORY IODINE DEFICIE
[3]   GENETIC AND CLINICAL-FEATURES OF 42 KINDREDS WITH RESISTANCE TO THYROID-HORMONE - THE NATIONAL-INSTITUTES-OF-HEALTH PROSPECTIVE-STUDY [J].
BRUCKERDAVIS, F ;
SKARULIS, MC ;
GRACE, MB ;
BENICHOU, J ;
HAUSER, P ;
WIGGS, E ;
WEINTRAUB, BD .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) :572-583
[4]   Co-repressors 2000 [J].
Burke, LJ ;
Baniahmad, A .
FASEB JOURNAL, 2000, 14 (13) :1876-1888
[5]   Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors [J].
Chen, JD ;
Li, H .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1998, 8 (02) :169-190
[6]  
Damjanovski Sashko, 2002, Methods Mol Biol, V202, P153
[7]   Nongenomic actions of thyroid hormone [J].
Davis, PJ ;
Davis, FB .
THYROID, 1996, 6 (05) :497-504
[8]  
Dodd M.H.I., 1976, P467
[9]  
ELICEIRI BP, 1994, J BIOL CHEM, V269, P24459
[10]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895